78 related articles for article (PubMed ID: 30400007)
1. KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC.
Wei X; Cai S; Boohaker RJ; Fried J; Li Y; Hu L; Pan Y; Cheng R; Zhang S; Tian Y; Gao M; Xu B
Endocr Relat Cancer; 2019 Jan; 26(1):141-151. PubMed ID: 30400007
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.
Johnson JM; Lai SY; Cotzia P; Cognetti D; Luginbuhl A; Pribitkin EA; Zhan T; Mollaee M; Domingo-Vidal M; Chen Y; Campling B; Bar-Ad V; Birbe R; Tuluc M; Martinez Outschoorn U; Curry J
Semin Oncol; 2015 Dec; 42(6):915-22. PubMed ID: 26615136
[TBL] [Abstract][Full Text] [Related]
3. The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.
Passaro C; Borriello F; Vastolo V; Di Somma S; Scamardella E; Gigantino V; Franco R; Marone G; Portella G
Oncotarget; 2016 Jan; 7(2):1500-15. PubMed ID: 26625205
[TBL] [Abstract][Full Text] [Related]
4. BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.
Jin T; Ding L; Chen J; Zou X; Xu T; Xuan Z; Wang S; Chen J; Wang W; Zhu C; Zhang Y; Huang P; Pan Z; Ge M
J Cell Mol Med; 2024 Apr; 28(7):e18182. PubMed ID: 38498903
[TBL] [Abstract][Full Text] [Related]
5. BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation.
Wang X; Ying T; Yuan J; Wang Y; Su X; Chen S; Zhao Y; Zhao Y; Sheng J; Teng L; Luo C; Wang W
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184950
[TBL] [Abstract][Full Text] [Related]
6. The m
Li P; Wang W; Zhou R; Ding Y; Li X
Clin Transl Med; 2023 Nov; 13(11):e1466. PubMed ID: 37983928
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2.
Zhuang S; Xie J; Zhen J; Guo L; Hong Z; Li F; Xu D
Mol Cell Endocrinol; 2021 Nov; 537():111440. PubMed ID: 34428509
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.
Garg M; Okamoto R; Nagata Y; Kanojia D; Venkatesan S; M T A; Braunstein GD; Said JW; Doan NB; Ho Q; Akagi T; Gery S; Liu LZ; Tan KT; Chng WJ; Yang H; Ogawa S; Koeffler HP
J Clin Endocrinol Metab; 2015 Feb; 100(2):725-35. PubMed ID: 25365311
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract][Full Text] [Related]
10. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
[TBL] [Abstract][Full Text] [Related]
11. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
Wu Y; Chen W; Miao H; Xu T
BMC Cancer; 2024 Feb; 24(1):210. PubMed ID: 38360598
[TBL] [Abstract][Full Text] [Related]
12. The Tudor-knot Domain of KAT5 Regulates Nucleosomal Substrate Acetylation.
Xuan F; Xuan H; Huang M; He W; Xu H; Shi X; Wen H
J Mol Biol; 2024 Apr; 436(7):168414. PubMed ID: 38141874
[TBL] [Abstract][Full Text] [Related]
13. Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters.
Pan Z; Lu X; Hu X; Yu R; Che Y; Wang J; Xiao L; Chen J; Yi X; Tan Z; Li F; Ling D; Huang P; Ge M
J Control Release; 2024 May; 369():517-530. PubMed ID: 38569942
[TBL] [Abstract][Full Text] [Related]
14. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
15. Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer.
Feng C; Tao Y; Yu C; Wang L; Liu X; Cao Y
Cancer Gene Ther; 2023 Dec; 30(12):1598-1609. PubMed ID: 37679527
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma.
Cho S; Kim H; Oh YL; Hahn SY; Kim TH; Shin JH
Sci Rep; 2023 Feb; 13(1):3264. PubMed ID: 36828842
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes.
Wang X; Lupton C; Lauth A; Wan TC; Foster P; Patterson M; Auchampach JA; Lough JW
J Mol Cell Cardiol; 2021 Jun; 155():88-98. PubMed ID: 33609538
[TBL] [Abstract][Full Text] [Related]
18. ENO2 promotes anoikis resistance in anaplastic thyroid cancer by maintaining redox homeostasis.
Zhang Y; Ji X; Wang Y
Gland Surg; 2024 Feb; 13(2):209-224. PubMed ID: 38455357
[TBL] [Abstract][Full Text] [Related]
19. Nasal tip metastasis: an unusual site and mode of spread in anaplastic thyroid carcinoma.
Kohli PS; Soni NK
Indian J Otolaryngol Head Neck Surg; 2008 Sep; 60(3):269-70. PubMed ID: 23120560
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.
Vasko V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
